1278P Hyperprogressive disease (HPD) upon first-line...

Annals of Oncology 2020 / 09 Vol. 31

1278P Hyperprogressive disease (HPD) upon first-line PD-1/PD-L1 inhibitors (ICI) as single agent or in combination with platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients (pts)

Ferrara, R., Facchinetti, F., Calareso, G., Kasraoui, I., Signorelli, D., Proto, C., Prelaj, A., Naltet, C., Lavaud, P., Desmaris, R., Viscardi, G., Galli, G., De Toma, A., Martinetti, A., Barlesi, F.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.1592
Date:
September, 2020
File:
PDF, 95 KB
2020
Conversion to is in progress
Conversion to is failed